Imunexus Therapeutics Limited
www.imunexus.comImunexus' technology facilitates rapid, cost-effective, lower risk, generation of effective therapeutics by converting existing monoclonal antibodies into multispecifics with additional therapeutic utility. Our technology will generate a number of potential products for the treatment of a number of cancers, autoimmune and other serious diseases.
Read moreImunexus' technology facilitates rapid, cost-effective, lower risk, generation of effective therapeutics by converting existing monoclonal antibodies into multispecifics with additional therapeutic utility. Our technology will generate a number of potential products for the treatment of a number of cancers, autoimmune and other serious diseases.
Read moreEmployees statistics
View all employeesPotential Decision Makers
Non Executive Director
Email ****** @****.comPhone (***) ****-****Chairperson
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Imunexus Therapeutics Limited
Free credits every month!
Imunexus Therapeutics Limited FAQ
Bundoora, Australia
Biotechnology Research